These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

746 related items for PubMed ID: 11531293

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. HPV Effectiveness in Lowgrade Paps (HELP) Study No. 1 Group.
    Lytwyn A, Sellors JW, Mahony JB, Daya D, Chapman W, Ellis N, Roth P, Lorincz AT, Gafni A.
    CMAJ; 2000 Sep 19; 163(6):701-7. PubMed ID: 11022584
    [Abstract] [Full Text] [Related]

  • 3. Managing atypical squamous cells of undetermined significance in Papanicolaou smears.
    Morin C, Bairati I, Bouchard C, Fortier M, Roy M, Moore L, Meisels A.
    J Reprod Med; 2001 Sep 19; 46(9):799-805. PubMed ID: 11584480
    [Abstract] [Full Text] [Related]

  • 4. High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.
    Denise Zielinski G, Snijders PJ, Rozendaal L, Voorhorst FJ, Runsink AP, de Schipper FA, Meijer CJ.
    J Pathol; 2001 Oct 19; 195(3):300-6. PubMed ID: 11673826
    [Abstract] [Full Text] [Related]

  • 5. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness.
    Kaufman RH, Adam E, Icenogle J, Reeves WC.
    Am J Obstet Gynecol; 1997 Oct 19; 177(4):930-6. PubMed ID: 9369847
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
    Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA.
    JAMA; 2002 Oct 09; 288(14):1749-57. PubMed ID: 12365959
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
    Zorzi M, Del Mistro A, Farruggio A, de'Bartolomeis L, Frayle-Salamanca H, Baboci L, Bertazzo A, Cocco P, Fedato C, Gennaro M, Marchi N, Penon MG, Cogo C, Ferro A.
    BJOG; 2013 Sep 09; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
    [Abstract] [Full Text] [Related]

  • 10. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
    Ferris DG, Wright TC, Litaker MS, Richart RM, Lorincz AT, Sun XW, Borgatta L, Buck H, Kramer L, Rubin R.
    J Fam Pract; 1998 Feb 09; 46(2):125-34. PubMed ID: 9487318
    [Abstract] [Full Text] [Related]

  • 11. Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on papanicolaou smears.
    Shlay JC, Dunn T, Byers T, Barón AE, Douglas JM.
    Obstet Gynecol; 2000 Sep 09; 96(3):410-6. PubMed ID: 10960635
    [Abstract] [Full Text] [Related]

  • 12. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study.
    Dane C, Batmaz G, Dane B, Cetin A.
    Ann Diagn Pathol; 2009 Apr 09; 13(2):73-7. PubMed ID: 19302953
    [Abstract] [Full Text] [Related]

  • 13. Cost and effectiveness comparison of immediate colposcopy versus human papillomavirus DNA testing in management of atypical squamous cells of undetermined significance in Turkish women.
    Kececioglu M, Seckin B, Baser E, Togrul C, Kececioglu TS, Cicek MN, Gungor T.
    Asian Pac J Cancer Prev; 2013 Apr 09; 14(1):511-4. PubMed ID: 23534785
    [Abstract] [Full Text] [Related]

  • 14. Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear.
    Monsonego J, Bohbot JM, Pollini G, Krawec C, Vincent C, Merignargues I, Haroun F, Sednaoui P, Monfort L, Dachez R, Syrjänen K.
    Gynecol Oncol; 2005 Oct 09; 99(1):160-8. PubMed ID: 16023184
    [Abstract] [Full Text] [Related]

  • 15. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance.
    ASCUS-LSIL Traige Study (ALTS) Group.
    Am J Obstet Gynecol; 2003 Jun 09; 188(6):1383-92. PubMed ID: 12824967
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico.
    Salmerón J, Lazcano-Ponce E, Lorincz A, Hernández M, Hernández P, Leyva A, Uribe M, Manzanares H, Antunez A, Carmona E, Ronnett BM, Sherman ME, Bishai D, Ferris D, Flores Y, Yunes E, Shah KV.
    Cancer Causes Control; 2003 Aug 09; 14(6):505-12. PubMed ID: 12948281
    [Abstract] [Full Text] [Related]

  • 19. Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear.
    Monsonego J, Pollini G, Evrard MJ, Sednaoui P, Monfort L, Quinzat D, Dachez R, Syrjänen K.
    Int J STD AIDS; 2008 Jun 09; 19(6):385-92. PubMed ID: 18595876
    [Abstract] [Full Text] [Related]

  • 20. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
    Safaeian M, Wright TC, Stoler MH, Ranger-Moore J, Rehm S, Aslam S, Fang Q, Volkir P, Ridder R.
    Am J Obstet Gynecol; 2021 Sep 09; 225(3):278.e1-278.e16. PubMed ID: 33852886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.